Robert M. Gow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Robert M. Gow has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- David Moher
Institute of Health Policy, Management & Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
2 shared publications Lillian Lai
The Children's Hospital of Eastern Ontario, University of Ottawa Faculty of Medicine, Ottawa, Canada
2 shared publications- Martin Stephen Green
University of Ottawa Heart Institute, Ontario, Canada (S.H., M.S.G.).
2 shared publications - Michael Howard Gollob
Department of Physiology, University of Toronto, Toronto, Canada
2 shared publications - Robert M. Hamilton
Department of Pediatrics, The Labatt Family Heart Centre and Translational Medicine, The Hospital for Sick Children & Research Institute and the University of Toronto , Room 1725D, 555 University Avenue, Toronto, ON M5G 1X8
2 shared publications Adrian Baranchuk
Queen's University, Kingston, Ontario, Canada
1 shared publication
Latest Publications
- 1 April 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 185, 114-116
Whole exome sequencing identifies the TNNI3K gene as a cause of familial conduction system disease and congenital junctional ectopic tachycardia
- 1 April 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 185, 114-116
Whole exome sequencing identifies the TNNI3K gene as a cause of familial conduction system disease and congenital junctional ectopic tachycardia
- Open Access
- 4 September 2014
- Published by Springer Nature in Systematic Reviews
- Vol. 3 (1) , 96
Do sugar-sweetened beverages cause adverse health outcomes in children? A systematic review protocol
Cardiovascular disease and type 2 diabetes are examples of chronic diseases that impose significant morbidity and mortality in the general population worldwide. Most chronic diseases are associated with underlying preventable risk factors, such as elevated blood pressure, high blood glucose or glucose intolerance, high lipid levels, physical inactivity, excessive sedentary behaviours, and overweight/obesity. The occurrence of intermediate outcomes during childhood increases the risk of disease in adulthood. Sugar-sweetened beverages are known to be significant sources of additional caloric intake, and given recent attention to their contribution in the development of chronic diseases, a systematic review is warranted. We will assess whether the consumption of sugar-sweetened beverages in children is associated with adverse health outcomes and what the potential moderating factors are. Of interest are studies addressing sugar-sweetened beverage consumption, taking a broad perspective. Both direct consumption studies as well as those evaluating interventions that influence consumption (e.g. school policy, educational) will be relevant. Non-specific or multi-faceted behavioural, educational, or policy interventions may also be included subject to the level of evidence that exists for the other interventions/exposures. Comparisons of interest and endpoints of interest are pre-specified. We will include randomized controlled trials, controlled clinical trials, interrupted time series studies, controlled before-after studies, prospective and retrospective comparative cohort studies, case–control studies, and nested case–control designs. The MEDLINE®, Embase, The Cochrane Library, CINAHL, ERIC, and PsycINFO® databases and grey literature sources will be searched. The processes for selecting studies, abstracting data, and resolving conflicts are described. We will assess risk of bias using design-specific tools. To determine sets of confounding variables that should be adjusted for, we have developed causal directed acyclic graphs and will use those to inform our risk of bias assessments. Meta-analysis will be conducted where appropriate; parameters for exploring statistical heterogeneity and effect modifiers are pre-specified. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to determine the quality of evidence for outcomes. PROSPERO CRD42014009641 .
- 4 September 2014
- Published by Springer Nature in Systematic Reviews
- Vol. 3 (1) , 96
Open AccessDo sugar-sweetened beverages cause adverse health outcomes in children? A systematic review protocol
Cardiovascular disease and type 2 diabetes are examples of chronic diseases that impose significant morbidity and mortality in the general population worldwide. Most chronic diseases are associated with underlying preventable risk factors, such as elevated blood pressure, high blood glucose or glucose intolerance, high lipid levels, physical inactivity, excessive sedentary behaviours, and overweight/obesity. The occurrence of intermediate outcomes during childhood increases the risk of disease in adulthood. Sugar-sweetened beverages are known to be significant sources of additional caloric intake, and given recent attention to their contribution in the development of chronic diseases, a systematic review is warranted. We will assess whether the consumption of sugar-sweetened beverages in children is associated with adverse health outcomes and what the potential moderating factors are. Of interest are studies addressing sugar-sweetened beverage consumption, taking a broad perspective. Both direct consumption studies as well as those evaluating interventions that influence consumption (e.g. school policy, educational) will be relevant. Non-specific or multi-faceted behavioural, educational, or policy interventions may also be included subject to the level of evidence that exists for the other interventions/exposures. Comparisons of interest and endpoints of interest are pre-specified. We will include randomized controlled trials, controlled clinical trials, interrupted time series studies, controlled before-after studies, prospective and retrospective comparative cohort studies, case–control studies, and nested case–control designs. The MEDLINE®, Embase, The Cochrane Library, CINAHL, ERIC, and PsycINFO® databases and grey literature sources will be searched. The processes for selecting studies, abstracting data, and resolving conflicts are described. We will assess risk of bias using design-specific tools. To determine sets of confounding variables that should be adjusted for, we have developed causal directed acyclic graphs and will use those to inform our risk of bias assessments. Meta-analysis will be conducted where appropriate; parameters for exploring statistical heterogeneity and effect modifiers are pre-specified. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to determine the quality of evidence for outcomes. PROSPERO CRD42014009641 .
- 1 February 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (2) , 239-245
Sudden cardiac death in children and adolescents between 1 and 19 years of age
- 1 February 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (2) , 239-245
Sudden cardiac death in children and adolescents between 1 and 19 years of age
- 1 November 2013
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 29 (11) , 1527-1530
Charting a Course for Cardiac Electrophysiology Training in Canada: The Vital Role of Fellows in Advanced Cardiovascular Care
- 1 November 2013
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 29 (11) , 1527-1530
Charting a Course for Cardiac Electrophysiology Training in Canada: The Vital Role of Fellows in Advanced Cardiovascular Care
- 23 May 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (3) , 357-359
Atrial Fibrillation in a LQTS Patient with an ICD Programmed for Managed Ventricular Pacing: What is the Cause?
- 23 May 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (3) , 357-359
Atrial Fibrillation in a LQTS Patient with an ICD Programmed for Managed Ventricular Pacing: What is the Cause?
- 15 August 2010
- Published by Taylor & Francis in Channels
- Vol. 4 (4) , 302-310
Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhythmogenic disease that manifests as syncope or sudden death during high adrenergic tone in the absence of structural heart defects. It is primarily caused by mutations in the cardiac ryanodine receptor (RyR2). The mechanism by which these mutations cause arrhythmia remains controversial, with discrepant findings related to the role of the RyR2 binding protein FKBP12.6. The purpose of this study was to characterize a novel RyR2 mutation identified in a kindred with clinically diagnosed CPVT. Single-strand conformational polymorphism analysis and direct DNA sequencing were used to screen the RyR2 gene for mutations. Site-directed mutagenesis was employed to introduce the mutation into the mouse RyR2 cDNA. The impact of the mutation on the interaction between RyR2 and a 12.6 kDa FK506 binding protein (FKBP12.6) was determined by immunoprecipitation and immunoblotting and its effect on RyR2 function was characterized by single cell Ca2+ imaging and [3H]ryanodine binding. A novel CPVT mutation, E189D, was identified. The E189D mutation does not alter the affinity of the channel for FKBP12.6, but it increases the propensity for store-overload-induced Ca2+ release (SOICR). Furthermore, the E189D mutation enhances the basal channel activity of RyR2 and its sensitivity to activation by caffeine. The E189D RyR2 mutation is causative for CPVT and functionally increases the propensity for SOICR without altering the affinity for FKBP12.6. These observations strengthen the notion that enhanced SOICR, but not altered FKBP12.6 binding, is a common mechanism by which RyR2 mutations cause arrhythmias.
- 15 August 2010
- Published by Taylor & Francis in Channels
- Vol. 4 (4) , 302-310
Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhythmogenic disease that manifests as syncope or sudden death during high adrenergic tone in the absence of structural heart defects. It is primarily caused by mutations in the cardiac ryanodine receptor (RyR2). The mechanism by which these mutations cause arrhythmia remains controversial, with discrepant findings related to the role of the RyR2 binding protein FKBP12.6. The purpose of this study was to characterize a novel RyR2 mutation identified in a kindred with clinically diagnosed CPVT. Single-strand conformational polymorphism analysis and direct DNA sequencing were used to screen the RyR2 gene for mutations. Site-directed mutagenesis was employed to introduce the mutation into the mouse RyR2 cDNA. The impact of the mutation on the interaction between RyR2 and a 12.6 kDa FK506 binding protein (FKBP12.6) was determined by immunoprecipitation and immunoblotting and its effect on RyR2 function was characterized by single cell Ca2+ imaging and [3H]ryanodine binding. A novel CPVT mutation, E189D, was identified. The E189D mutation does not alter the affinity of the channel for FKBP12.6, but it increases the propensity for store-overload-induced Ca2+ release (SOICR). Furthermore, the E189D mutation enhances the basal channel activity of RyR2 and its sensitivity to activation by caffeine. The E189D RyR2 mutation is causative for CPVT and functionally increases the propensity for SOICR without altering the affinity for FKBP12.6. These observations strengthen the notion that enhanced SOICR, but not altered FKBP12.6 binding, is a common mechanism by which RyR2 mutations cause arrhythmias.
- 14 April 2009
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 14 (2) , 165-175
The Measurement of the QT and QTc on the Neonatal and Infant Electrocardiogram: A Comprehensive Reliability Assessment
Background: An electrocardiogram has been proposed to screen for prolonged QT interval that may predispose infants to sudden death in the first year of life. Understanding the reliability of QT interval measurement will inform the design of a screening program. Methods: Three pediatric cardiologists measured the QT/RR intervals on 60 infant electrocardiograms (median age 46 days), from leads II, V5 and V6 on three separate occasions, 7 days apart, according to a standard protocol. The QTc was corrected by Bazett's (QTcB), Fridericia's (QTCFrid), and Hodges' (QTcH) formulae. Intraobserver and interobserver reliability were assessed by intraclass correlation coefficients (ICC), limits of agreement and repeatability coefficients for single, average of two and average of three measures. Agreement for QTc prolongation (> 440 msec) was assessed by kappa coefficients. Results: QT interval intraobserver ICC was 0.86 and repeatability coefficient was 25.9 msec; interobserver ICC increased from 0.88 for single observations to 0.94 for the average of 3 measurements and repeatability coefficients decreased from 22.5 to 16.7 msec. For QTcB, intraobserver ICC was 0.67, and repeatability was 39.6 msec. Best interobserver reliability for QTcB was for the average of three measurements (ICC 0.83, reproducibility coefficient 25.8 msec), with further improvement for QTcH (ICC 0.92, reproducibility coefficient 16.69 msec). Maximum interobserver kappa for prolonged QTc was 0.77. Misclassification around specific cut points occurs because of the repeatability coefficients. Conclusions: Uncorrected QT measures are more reliable than QTcB and QTCFrid. An average of three independent measures provides the most reliable QT and QTc measurements, with QTcH better than QTcB.
- 14 April 2009
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 14 (2) , 165-175
The Measurement of the QT and QTc on the Neonatal and Infant Electrocardiogram: A Comprehensive Reliability Assessment
Background: An electrocardiogram has been proposed to screen for prolonged QT interval that may predispose infants to sudden death in the first year of life. Understanding the reliability of QT interval measurement will inform the design of a screening program. Methods: Three pediatric cardiologists measured the QT/RR intervals on 60 infant electrocardiograms (median age 46 days), from leads II, V5 and V6 on three separate occasions, 7 days apart, according to a standard protocol. The QTc was corrected by Bazett's (QTcB), Fridericia's (QTCFrid), and Hodges' (QTcH) formulae. Intraobserver and interobserver reliability were assessed by intraclass correlation coefficients (ICC), limits of agreement and repeatability coefficients for single, average of two and average of three measures. Agreement for QTc prolongation (> 440 msec) was assessed by kappa coefficients. Results: QT interval intraobserver ICC was 0.86 and repeatability coefficient was 25.9 msec; interobserver ICC increased from 0.88 for single observations to 0.94 for the average of 3 measurements and repeatability coefficients decreased from 22.5 to 16.7 msec. For QTcB, intraobserver ICC was 0.67, and repeatability was 39.6 msec. Best interobserver reliability for QTcB was for the average of three measurements (ICC 0.83, reproducibility coefficient 25.8 msec), with further improvement for QTcH (ICC 0.92, reproducibility coefficient 16.69 msec). Maximum interobserver kappa for prolonged QTc was 0.77. Misclassification around specific cut points occurs because of the repeatability coefficients. Conclusions: Uncorrected QT measures are more reliable than QTcB and QTCFrid. An average of three independent measures provides the most reliable QT and QTc measurements, with QTcH better than QTcB.
- Open Access
- 1 March 2009
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 14 (3) , 185-188
Preventing sudden cardiac death in the young: Is electrocardiogram screening the most effective means?
The sudden and unexpected death of a young person is an infrequent event, although it has become an important public health issue. Factors contributing to the increasing profile are the long-standing debates over pre-participation screening for young athletes, the apparent success of this screening in some jurisdictions, as well as concerns about the possible risk of stimulant medication for attention-deficit hyperactivity disorder. In fact, this latter consideration resulted in a recent document (1) from the American Heart Association that devoted a large portion to discussion of the issues related to the usefulness of electrocardiogram (ECG) screening.
- 1 March 2009
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 14 (3) , 185-188
Open AccessPreventing sudden cardiac death in the young: Is electrocardiogram screening the most effective means?
The sudden and unexpected death of a young person is an infrequent event, although it has become an important public health issue. Factors contributing to the increasing profile are the long-standing debates over pre-participation screening for young athletes, the apparent success of this screening in some jurisdictions, as well as concerns about the possible risk of stimulant medication for attention-deficit hyperactivity disorder. In fact, this latter consideration resulted in a recent document (1) from the American Heart Association that devoted a large portion to discussion of the issues related to the usefulness of electrocardiogram (ECG) screening.
- 30 April 2008
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 61 (4) , 394-401
A review of five cardiology journals found that observer variability of measured variables was infrequently reported
- 30 April 2008
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 61 (4) , 394-401
A review of five cardiology journals found that observer variability of measured variables was infrequently reported
- 1 February 2002
- Published by Springer Nature in Cardiac Electrophysiology Review
- Vol. 6 (1-2) , 112-114
Myocardial Bridging: Does It Cause Sudden Death?
- 1 February 2002
- Published by Springer Nature in Cardiac Electrophysiology Review
- Vol. 6 (1-2) , 112-114
Myocardial Bridging: Does It Cause Sudden Death?